Bielecka, E.; Zubrzycka, N.; Marzec, K.; Maksylewicz, A.; Sochalska, M.; Kulawik-Pióro, A.; Lasoń, E.; Śliwa, K.; Malinowska, M.; Sikora, E.;
et al. Ursolic Acid Formulations Effectively Induce Apoptosis and Limit Inflammation in the Psoriasis Models In Vitro. Biomedicines 2024, 12, 732.
https://doi.org/10.3390/biomedicines12040732
AMA Style
Bielecka E, Zubrzycka N, Marzec K, Maksylewicz A, Sochalska M, Kulawik-Pióro A, Lasoń E, Śliwa K, Malinowska M, Sikora E,
et al. Ursolic Acid Formulations Effectively Induce Apoptosis and Limit Inflammation in the Psoriasis Models In Vitro. Biomedicines. 2024; 12(4):732.
https://doi.org/10.3390/biomedicines12040732
Chicago/Turabian Style
Bielecka, Ewa, Natalia Zubrzycka, Karolina Marzec, Anna Maksylewicz, Maja Sochalska, Agnieszka Kulawik-Pióro, Elwira Lasoń, Karolina Śliwa, Magdalena Malinowska, Elżbieta Sikora,
and et al. 2024. "Ursolic Acid Formulations Effectively Induce Apoptosis and Limit Inflammation in the Psoriasis Models In Vitro" Biomedicines 12, no. 4: 732.
https://doi.org/10.3390/biomedicines12040732
APA Style
Bielecka, E., Zubrzycka, N., Marzec, K., Maksylewicz, A., Sochalska, M., Kulawik-Pióro, A., Lasoń, E., Śliwa, K., Malinowska, M., Sikora, E., Nowak, K., Miastkowska, M., & Kantyka, T.
(2024). Ursolic Acid Formulations Effectively Induce Apoptosis and Limit Inflammation in the Psoriasis Models In Vitro. Biomedicines, 12(4), 732.
https://doi.org/10.3390/biomedicines12040732
